Its overexpression also induces classic epithelial markers (e.g., E-Cadherin) and reduces mesenchymal markers (e.g., Vimentin) in prostate cancer cells PC3 and LN3 (Fig. 2B−C). Here, CDH1 is linked to prostate carcinoma.